MedPath

A Randomised Double Blind Placebo Controlled Trial-Local Anaesthesia and Pain Perception during Amniocentesis

Not Applicable
Completed
Conditions
Health Condition 1: O359- Maternal care for (suspected) fetal abnormality and damage, unspecified
Registration Number
CTRI/2020/10/028469
Lead Sponsor
AIIMS Jodhpur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
138
Inclusion Criteria

Singleton pregnancy and gestational age 15-24 weeks based on reliable last menstrual period and/or sonographic biometry in 1st trimester of pregnancy (11 to 13+6 weeks) having following indications-

h/o chromosomal abnormality in baby

high risk/intermediate risk cases according to aneuploidy results

Nuchal translucency >3.5 mm

Previous syndromic baby ,parents having balanced translocation,usg suggestive of any structural abnormality

Exclusion Criteria

patient having history of lignocaine allrgy

inability to rate pain score by visual analogue scale

patient refusal

abnormal sensory function based on history

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath